Your email has been successfully added to our mailing list.

×
0 0 0 0.048 -0.024 -0.067 -0.118 -0.136
Stock impact report

Global Brain Tumor Drugs Market Expected to Exceed $3 Billion Through 2022

CNS Pharmaceuticals, Inc. (CNSP)  More Company Research Source: PR Newswire
PDF PALM BEACH, Florida, Jan. 14, 2020 /PRNewswire/ -- Targeted cancer therapies are drugs or substances which block the growth of cancer by interfering with molecules that are more specifically involved in cancer cell progression than in normal cell activity. The goal of targeted cancer therapies is to eliminate cancerous cells in the body while leaving normal cells unharmed. By focusing on changes in the cell that are specific to cancer, this therapy may prove to be more effective than traditional chemotherapy and radiotherapy. The brain tumor drugs market consist of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain. These drugs are either used alone or in combinations, depending on the type, size and locations of the tumor. The global brain tumor drugs market is expected to grow to $3.41 billion at a CAGR of 9.2% through 2022. This rising popularity of targeted therapies is expected to affect the sales of conventional chemical Brain Tumor drugs, t [Read more]
Impact snapshot Event time: CNSP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
CNSP alerts
from News Quantified
Opt-in for
CNSP alerts

from News Quantified
Opt-in for
CNSP alerts

from News Quantified